Plasma metabolomics in EGC patients during PD-L1 based immunotherapy

The PUCH Center's cohort of EGC (gastroesophagus cancer) patients undergoing immunotherapy aims to explore the corresponding plasma metabolomic changes associated with alterations in body composition during immunotherapy.

PUCH中心针对接受免疫治疗的胃食管癌（gastroesophageal cancer, EGC）患者所开展的队列研究，旨在探究免疫治疗过程中与身体成分改变相关的血浆代谢组学变化。